# Treatment for Subjects With Non-Hodgkin's Lymphoma

> **NCT00117897** · PHASE2 · COMPLETED · sponsor: **Amgen**

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** pegfilgrastim
- **DRUG:** Filgrastim

## Key facts

- **NCT ID:** NCT00117897
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2004-02
- **Target enrollment:** — (—)
- **Last updated:** 2009-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117897, "Treatment for Subjects With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00117897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*